MyAverix Finance
US · Healthcare
Sagimet Biosciences Inc. Series A Common Stock (SGMT)
Biotechnology
Sagimet Biosciences Inc. Series A Common Stock (SGMT) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for SGMT
Sagimet Biosciences Inc. Series A Common Stock (SGMT) — FAQ
What is SGMT's P/E ratio?
The price-to-earnings (P/E) ratio for Sagimet Biosciences Inc. Series A Common Stock (SGMT) is 25.00 (data as of 2026-05-23).
Does Sagimet Biosciences Inc. Series A Common Stock pay a dividend?
Dividend yield is not available in the current snapshot for Sagimet Biosciences Inc. Series A Common Stock (SGMT). Check the MyAverix Finance app for the latest dividend data.
What sector is Sagimet Biosciences Inc. Series A Common Stock in?
Sagimet Biosciences Inc. Series A Common Stock (SGMT) is classified in the Healthcare sector (Biotechnology industry).
What exchange is SGMT listed on?
SGMT is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.